Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

59.96
Delayed Data
As of Jan 17
 -0.92 / -1.51%
Today’s Change
35.41
Today|||52-Week Range
74.50
+40.39%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close60.88
Today’s open61.75
Day’s range59.42 - 61.75
Volume736,586
Average volume (3 months)605,891
Market cap$3.5B
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+44.24%
Earnings growth (this year)-74.61%
Earnings growth (next 5 years)+86.06%
Revenue growth (last year)+1,871.48%
P/E ratioNM
Price/Sales42.03
Price/Book5.01

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-4.14-3.76%
MYOKMyoKardia Inc-1.44-1.92%
AGIOAgios Pharmaceutical...+1.31+2.54%
PTCTPTC Therapeutics Inc+1.33+2.53%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateFebruary 18, 2020
EPS forecast (this quarter)-$1.61
Annual revenue (last year)$51.5M
Annual profit (last year)-$197.6M
Net profit margin-383.75%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Novato, California

Forecasts